Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spectinomycin.

W J Holloway

    The Medical Clinics of North America
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Spectinomycin is a highly effective antibiotic for treating gonorrhea, especially when other treatments fail or for penicillin-allergic patients. It is the preferred choice for gonorrhea in regions with penicillinase-producing Neisseria gonorrhoeae strains.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.

    Antimicrobial agents and chemotherapy·2000
    Same author

    In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

    Antimicrobial agents and chemotherapy·1999
    Same author

    1998 William J. Stickel Bronze Award. Antifungal activity of Melaleuca alternifolia (tea-tree) oil against various pathogenic organisms.

    Journal of the American Podiatric Medical Association·1998
    Same author

    Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes.

    The Journal of antimicrobial chemotherapy·1997
    Same author

    In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.

    Antimicrobial agents and chemotherapy·1996
    Same author

    Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.

    The American journal of medicine·1996
    Same journal

    Care Transitions Continue to Evolve.

    The Medical clinics of North America·2026
    Same journal

    Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

    The Medical clinics of North America·2026
    Same journal

    Care Transitions and Value-Based Payment Models in the United States.

    The Medical clinics of North America·2026
    Same journal

    Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

    The Medical clinics of North America·2026
    Same journal

    Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

    The Medical clinics of North America·2026
    Same journal

    Social Determinants of Health: Unique Considerations in Transitions of Care.

    The Medical clinics of North America·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Microbiology
    • Infectious Diseases

    Background:

    • Gonorrhea, caused by Neisseria gonorrhoeae, presents significant treatment challenges.
    • Emerging antibiotic resistance necessitates alternative therapeutic options.
    • Penicillin allergy complicates standard gonorrhea treatment regimens.

    Purpose of the Study:

    • To evaluate the efficacy of spectinomycin in treating uncomplicated gonorrhea.
    • To assess spectinomycin as a treatment option for penicillin-allergic individuals.
    • To determine spectinomycin's role in areas with prevalent penicillinase-producing Neisseria gonorrhoeae.

    Main Methods:

    • Clinical evaluation of spectinomycin's effectiveness.
    • Assessment of treatment outcomes in specific patient populations.

    Related Experiment Videos

  • Consideration of geographic prevalence of resistant strains.

    • Main Results:

    • Spectinomycin demonstrates high efficacy in uncomplicated gonorrhea.
    • It is a preferred treatment for resistant gonorrhea and a viable option for penicillin-allergic patients.
    • Its use is particularly recommended in regions with penicillinase-producing Neisseria gonorrhoeae.

    Conclusions:

    • Spectinomycin is a valuable antibiotic for gonorrhea treatment, especially in specific clinical scenarios.
    • Its utility is primarily confined to Neisseria gonorrhoeae infections.
    • Further consideration for oral pharyngeal gonorrhea and disseminated disease in allergic patients is noted.